NCT03207906View on ClinicalTrials.gov

A Trial to Evaluate the Efficacy and Safety of Two Concentrations of VBP-926 Solution for the Treatment of Chemotherapy-associated Paronychia in Cancer Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

102

Participants

Timeline

Start Date

October 24, 2017

Primary Completion Date

July 17, 2018

Study Completion Date

September 18, 2018

Conditions

Chemotherapy-Associated Paronychia

Interventions

DRUG

VBP-926

Topical VBP-926 solution

Trial Locations (8)

10022

Memorial Sloan Kettering Cancer Center, New York

10461

Montefiore Einstein Center for Cancer Care, The Bronx

19010

Bryn Mawr Skin & Cancer Institute, Bryn Mawr

28207

Oncology Specialists of Charlotte, Charlotte

43221

Ohio State University, Columbus

60611

Northwestern University Department of Dermatology, Chicago

63130

Washington University, St Louis

92708

Compassionate Cancer Care, Fountain Valley

All Listed Sponsors

lead

Veloce BioPharma LLC

INDUSTRY

NCT03207906 - A Trial to Evaluate the Efficacy and Safety of Two Concentrations of VBP-926 Solution for the Treatment of Chemotherapy-associated Paronychia in Cancer Patients | Biotech Hunter | Biotech Hunter